Moreover, we evaluated the incorporation of AGO in a novel topical delivery system like a microemulsion (ME), which is an ideal therapeutic approach for chronic neurological disorders in elderly people, especially in AD [33]. Here, FBXW7 is linked to Alzheimer disease.